FDA advisory panel votes in favor of Pfizer’s coronavirus vaccine

Thursday afternoon, the U.S. Food and Drug Administration’s panel of outside advisors voted the Pfizer COVID-19 vaccine benefits outweigh its risk for use in individuals 16 years of age and older, effectively endorsing Pfizer’s coronavirus vaccine for emergency use authorization approval in the United States. Read More